Exposure–response relationship of ramucirumab in East Asian patients from RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer
Crossref DOI link: https://doi.org/10.1007/s10120-017-0737-2
Published Online: 2017-06-20
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Tae You
Yen, Chia-Jui
Al-Batran, Salah-Eddin
Ferry, David
Gao, Ling
Hsu, Yanzhi
Cheng, Rebecca
Orlando, Mauro
Ohtsu, Atsushi
Funding for this research was provided by:
Eli Lilly and Company
License valid from 2017-06-20